Flu_PriceFile_Path_23-24.pdf

This document is an MMCAP Infuse Influenza Price File for the 2023-2024 season, representing a contract repository system that serves multiple member organizations. MMCAP Infuse operates as a pharmaceutical contracting consortium that provides members access to negotiated contracts with various pharmaceutical vendors. The system includes participating vendors such as AstraZeneca Pharmaceuticals LP, GlaxoSmithKline LLC (GSK), Sanofi Pasteur, and Seqirus USA, Inc., with contract numbers ranging from MMS1900102 to MMS2200579 covering different contract terms from 2018-2024.

The contracts focus specifically on influenza vaccines and related pharmaceutical products, with vendors offering various contract terms spanning multiple years. The document provides access to pricing information, insurance documentation, and procurement documents for the 2023-2024 influenza season. Key contract periods include current 2023-2024 agreements with GlaxoSmithKline and Sanofi Pasteur, as well as historical contracts dating back to 2018. The repository system allows members to search and filter contracts by vendor name, contract number, and category, providing access to supporting documents including pricing files, insurance certificates, and specialized forms like GSK declaration forms and Sanofi influenza vaccine prebooks. The pricing structure appears to be negotiated at the consortium level, offering members standardized pricing across multiple pharmaceutical suppliers.